Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Array BioPharma Inc. - Array BioPharma Initiates Clinical Trial in Type 2 Diabetic Patients
ASTERAND PLC - Asterand Compound Licensed to BTG is Progressing Well in Clinical Development
Asthma - Aerovance Secures $38 Million in Equity Financing
Bone Marrow Transplantation - Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
Cancer - Medivation Announces Publication in Science Describing MDV3100's Novel and Potent Anti-Androgen Properties
Celsion Corporation - Celsion Announces Promising Phase I ThermoDox® Results in Breast Cancer Presented at the Annual Meeting of the Society for Thermal Medicine
Depomed, Inc. - Depomed Completes Enrollment of Serada’s Full Phase 3 Clinical Program in Menopausal Hot Flashes
Diabetes - Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
Medifocus Inc. - Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Large Breast Cancer Tumors
Melanoma - Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
Mithridion, Inc. - Mithridion Announces Phase I Study Results in Alzheimer’s Disease
OncoVista Innovative Therapies, Inc. - Cancer Therapy & Research Center at the University of Texas Health Science Center and OncoVista Innovative Therapies, Inc. Announce the Initiation of Collaboration on the Clinical Development of OVI-117
Osiris Therapeutics, Inc. - First Patient Treated in Osiris Phase II Stem Cell Trial for Heart Attacks
Othera Pharmaceuticals, Inc. - OTHERA Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD
Pfizer Inc - Pfizer Becomes the First Pharmaceutical Company To Be Accredited for Protection of Human Rights In Clinical Research
Pfizer Inc - Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
Pfizer Inc - Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue
Pharmaceuticals - Orcrist Bio Inc. Receives Approval From European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750